Rodney Young
Director of Finance/CFO at RAPT THERAPEUTICS, INC.
Net worth: 105 353 $ as of 31/03/2024
Network origin in Rodney Young first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.
10
| Extinct | Biotechnology | 10 |
Cellerant Therapeutics, Inc.
 Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA.
2
| Holding Company | Medical Specialties | 2 |
| Subsidiary | Pharmaceuticals: Major | 2 | |
Extropy Pharmaceuticals, Inc.
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rodney Young via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Medical Specialties | Corporate Officer/Principal | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| CERUS CORPORATION | Medical Specialties | Public Communications Contact Corporate Officer/Principal | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Prolacta Bioscience, Inc.
 Prolacta Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in Duarte, CA. | Pharmaceuticals: Other | Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investment Managers | Private Equity Investor | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Miramar Technologies, Inc
 Miramar Technologies, Inc Medical SpecialtiesHealth Technology Miramar Technologies, Inc. develops and provides medical devices for dermatologic medical conditions. It specializes in microwave energy positioned to be adopted for dermatologic conditions. The company was founded by Henry A. Plain Jr., Mark E. Deem and Steven Kim in 2006 and is headquartered in Half Moon Bay, CA. | Medical Specialties | Director/Board Member | |
Promentis Pharmaceuticals, Inc.
 Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI. | Pharmaceuticals: Major | Director/Board Member | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
| Drexel University | College/University | Doctorate Degree | |
| XENOPORT, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| The College of New Jersey | College/University | Doctorate Degree | |
| Yale University | College/University | Graduate Degree | |
| San Francisco State University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Human Resources Officer | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Founder Private Equity Investor | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
Akceli, Inc.
 Akceli, Inc. Drugstore ChainsRetail Trade Akceli, Inc. operates pharmacies and drug stores. The private company is based in Cambridge, MA. The company was founded by David Chao. | Drugstore Chains | Corporate Officer/Principal | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AVROBIO, INC. | Biotechnology | Director/Board Member | |
| MIRAMAR LABS INC | Medical Specialties | Director/Board Member | |
| CONTINEUM THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003. | Pharmaceuticals: Major | Chief Executive Officer | |
| ARIDIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 51 |
Sectoral
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 162 |
| Corporate Officer/Principal | 90 |
| Independent Dir/Board Member | 60 |
| Chief Tech/Sci/R&D Officer | 35 |
| Chairman | 32 |
Most connected contacts
| Insiders | |
|---|---|
| Mark McDade | 35 |
| Michael Perry | 28 |
| Mary Gray | 27 |
| David Goeddel | 27 |
| Peter Svennilson | 25 |
| R. Scott Greer | 23 |
| Lowell E. Sears | 22 |
| Eliseo Salinas | 22 |
| Stacey Seltzer | 21 |
| William Rieflin | 16 |
| Des H. O’Connell | 15 |
| Sylvia R. Wheeler | 14 |
| Stewart Craig | 13 |
| Wendye Robbins | 12 |
| Lori Lyons-Williams | 11 |
- Stock Market
- Insiders
- Rodney Young
- Company connections